Osprey Biotechnics
Osprey Biotechnics, now the Phibro Biotechnics division of Phibro Animal Health Corporation, provides B2B microbial contract manufacturing services—including toll fermentation, pilot fermentation, and commercial scale-up of Pseudomonas and Bacillus strains—and sells proprietary branded microbial products for cleaning, bioremediation, and agricultural applications from its GMP-certified Sarasota, Florida facility.
- Company typePrivate
- Founded1963
- HeadquartersSarasota, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Osprey Biotechnics does
Osprey Biotechnics is a microbial contract manufacturing organization specializing in large-scale fermentation of bacterial strains—primarily the genera Pseudomonas and Bacillus—for environmental, industrial, and agricultural applications. The company operates from a GMP-certified facility in Sarasota, Florida, offering over 50,000 liters of fermentation capacity at that site, which extends to over 1 million liters when including other Phibro facilities. Its core service offering includes toll fermentation, pilot fermentation, commercial scale-up, and downstream processing into stabilized liquids, lyophilized powders, spray dried powders, dry powder concentrates, bottled liquids, and sachet packaging. Beyond custom manufacturing, Osprey/Phibro Biotechnics sells proprietary branded products including Munox (fats, oils, and grease degradation), Bacilox XL (cleaning and odor mitigation), Abundance (biological fertilizer companion), and MicroAlly (biological seed treatment), with several products recognized by the US EPA's Safer Choice Program.
The company generates revenue through three streams: (1) fee-for-service contract manufacturing arrangements priced by fermentation volume and complexity, (2) finished packaged goods manufacturing including formulation, packaging, and regulatory support, and (3) direct sales of proprietary branded microbial products. Its go-to-market is sales-led and B2B, targeting two primary customer segments: start-ups and innovators needing end-to-end microbial manufacturing from benchtop to commercial scale, and global leaders seeking to supplement in-house manufacturing capacity. Additional end markets include household/industrial/institutional (HI&I) cleaning, agricultural seed treatment and fertilizer, and environmental bioremediation.
Osprey Biotechnics was acquired by Phibro Animal Health Corporation (NASDAQ: PAHC) and now operates as the Phibro Biotechnics division. As a subsidiary of a publicly traded animal health and nutrition company, its microbial manufacturing platform is positioned within PAHC's broader portfolio spanning animal health, mineral nutrition, plant nutrition, and performance products. The acquisition integrated Osprey's 20+ years of microbial manufacturing expertise with PAHC's global distribution network and regulatory infrastructure.
Osprey Biotechnics firmographics
Firmographics- Name
- Osprey Biotechnics
- Legal name
- Osprey Biotechnics
- Website
- https://ospreybiotechnics.com
- Company type
- Private
- Founded year
- 1963
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- Osprey Biotechnics, now the Phibro Biotechnics division of Phibro Animal Health Corporation, provides B2B microbial contract manufacturing services—including toll fermentation, pilot fermentation, and commercial scale-up of Pseudomonas and Bacillus strains—and sells proprietary branded microbial products for cleaning, bioremediation, and agricultural applications from its GMP-certified Sarasota, Florida facility.
- Ownership category
- akta.pro rank
Osprey Biotechnics industry classification
Industry- Product category
- Microbial Contract Manufacturing
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment) (HLAAAJAJ)
- akta.pro secondary industry
- Probiotic/Direct-Fed Microbial (DFM) Premixes (AFADAGAG)
Keywords
Where Osprey Biotechnics is headquartered
LocationHeadquarters
- HQ city
- Sarasota
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Osprey Biotechnics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Revenue model
- Custom/Toll Fermentation Services: Contract manufacturing services for microbial fermentation, including toll fermentation, pilot fermentation, and commercial scale-up. Revenue generated through fee-for-service arrangements based on fermentation volume, complexity, and specific client requirements.
- Finished Packaged Goods Manufacturing: Finished product manufacturing including formulation development, packaging (liquid, powder, sachet), shelf life and stability testing, and regulatory support.
- Proprietary Microbial Products: Sale of branded microbial products including Munox (fats, oils, grease degradation), Bacilox (soil degradation, odor mitigation), Abundance biological fertilizer, and MicroAlly seed treatment products.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Osprey Biotechnics product offering
Product offeringCore offering
Osprey Biotechnics (now operating as Phibro Biotechnics, a division of Phibro Animal Health Corporation) provides microbial contract manufacturing services, including custom/toll fermentation of Pseudomonas and Bacillus strains, pilot fermentation, and commercial scale-up. The company also manufactures and sells proprietary microbial products for environmental, industrial, agricultural, and household/institutional applications from its GMP-certified Sarasota, Florida facility.
Product overview
Phibro Biotechnics (formerly the Osprey Biotechnics division) operates as a multi-platform microbial manufacturing and products company with three core divisions: (1) Phibro Biotechnics Microbial Contract Manufacturing — providing expert toll fermentation, pilot fermentation, and commercial scale-up services for Pseudomonas and Bacillus strains with over 1 million liters of total fermentation capacity; (2) Phibro Microbial Home & Industrial Solutions — delivering EPA Safer Choice-recognized products including Munox for fats/oils/grease degradation and Bacilox XL spore-forming concentrates for cleaning and bioremediation; and (3) Phibro Plant Solutions — offering Abundance biological fertilizer companions and MicroAlly seed treatments for agricultural applications. All manufacturing is conducted at the GMP-certified Sarasota, Florida facility.
Differentiator
Problem solved
Functional benefit
Brands
- Phibro Microbial Home & Industrial Solutions: Provides environmentally sustainable, microbial based materials for household, industrial and institutional sectors, specializing in fermentation of beneficial bacterial strains for cleaning, fats; oils and grease degradation; water treatment and bioremediation applications.
- Phibro Plant Solutions
- Munox
- Bacilo XL
- Abundance
- MicroAlly
Products and services
- Microbial Contract Manufacturing Services
Companies that use Osprey Biotechnics
Customer profileSegments5 records
Ideal customer profiles4 records
Osprey Biotechnics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Osprey Biotechnics partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Osprey Biotechnics competitors and assessment
Company assessmentBroad incumbents
- Lonza Group: One of the world's largest CDMOs with extensive microbial fermentation capabilities across biologics, enzymes, and industrial biotech — directly comparable as a contract manufacturer serving large-scale fermentation needs.
- Novonesis (Novozymes / Chr. Hansen): Global leader in microbial and enzyme solutions with precision fermentation at industrial scale — directly comparable business model combining proprietary microbial products with custom fermentation capabilities.
- Eurofins Scientific: Global life sciences services group providing contract biological testing, R&D, and manufacturing support — comparable through commercial physical and biological research services for biotech clients.
- IFF (International Flavors & Fragrances) — Health & Biosciences: Major producer of cultures, probiotics, and enzymes through precision fermentation — direct overlap with proprietary microbial cultures and contract fermentation services for HI&I, food, and agriculture.
- Catalent (Novo Holdings): Large CDMO with broad biologics manufacturing capabilities including microbial expression systems — competes for contract fermentation clients needing GMP-grade microbial manufacturing services.
- Kerry Group: Global taste and nutrition company with substantial fermentation capabilities producing microbial cultures and ingredients — overlaps in contract microbial manufacturing and Bacillus-based product offerings.
Emerging players
- BioResource International: Specialty fermentation company producing functional proteins and microbial products using Bacillus and other strains — overlaps in microbial fermentation technology and agricultural/industrial applications.
Direct peers
- Lallemand: Privately held Canadian company specializing in yeast and bacterial fermentation for agriculture, brewing, and industrial applications — comparable microbial manufacturing capabilities and customer overlap in HI&I and ag biologicals.
- AB Biotics (AB Enzymes / ABF Ingredients): Industrial enzyme and microbial product manufacturer with custom fermentation services — comparable in offering toll fermentation and proprietary microbial products for industrial and agricultural markets.
Others
- Phibro Animal Health Corporation: Public parent company (NASDAQ: PAHC) that owns Osprey/Phibro Biotechnics; not a peer but a key ecosystem relationship providing distribution, capital, and corporate infrastructure for the division.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Osprey Biotechnics social profiles
Digital presenceOsprey Biotechnics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Osprey Biotechnics leadership team
Management profileNumber of profiles
Osprey Biotechnics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Osprey Biotechnics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Osprey Biotechnics
What does Osprey Biotechnics do?
Osprey Biotechnics (now operating as Phibro Biotechnics, a division of Phibro Animal Health Corporation) provides microbial contract manufacturing services, including custom/toll fermentation of Pseudomonas and Bacillus strains, pilot fermentation, and commercial scale-up. The company also manufactures and sells proprietary microbial products for environmental, industrial, agricultural, and household/institutional applications from its GMP-certified Sarasota, Florida facility.
Is Osprey Biotechnics a public or private company?
Osprey Biotechnics is a private company. It is classified as corporate owned and is currently acquired.
When was Osprey Biotechnics founded?
Osprey Biotechnics was founded in 1963. It employs 1 to 10 people.
Where is Osprey Biotechnics based?
Osprey Biotechnics is headquartered in Sarasota, United States, in the North America region.
How does Osprey Biotechnics make money?
Three revenue lines are on record. Custom/Toll Fermentation Services are the primary driver. The others are finished Packaged Goods Manufacturing and proprietary Microbial Products.
Who are Osprey Biotechnics's main competitors?
Broad incumbents on record are Lonza Group, Novonesis (Novozymes / Chr. Hansen), Eurofins Scientific, IFF (International Flavors & Fragrances) — Health & Biosciences, Catalent (Novo Holdings) and Kerry Group. BioResource International is listed as an emerging player. Direct peers are Lallemand and AB Biotics (AB Enzymes / ABF Ingredients). Phibro Animal Health Corporation is listed as an others.
Does Osprey Biotechnics have an API?
No public API is recorded for Osprey Biotechnics.
What industry is Osprey Biotechnics in?
Osprey Biotechnics's product category is Microbial Contract Manufacturing. Its primary akta.pro industry code is HLAAAJAJ, Bioprocess Facility, Cleanroom & Utility Systems (HVAC, WFI, CIP/SIP, containment), with a secondary code of AFADAGAG, Probiotic/Direct-Fed Microbial (DFM) Premixes. Its NAICS code is 541714 and its SIC code is 8731.